CPE and type 2 diabetes mellitus: While islets of donors with type 2 diabetes do not display reduced expression of PC1/3 (also known as PCSK1) and/or CPE mRNA [33, 78], one study found that palmitate treatment of islets isolated from non-diabetic deceased organ donors reduced CPE protein levels [79].